AI assistant
Sending…
Norcod — Investor Presentation 2023
Jun 1, 2023
3675_rns_2023-06-01_3c5b5ca3-c89e-4a94-b0a7-6c07a2cbdf49.pdf
Investor Presentation
Open in viewerOpens in your device viewer




CFO: Arne Kristian Hoset

Agenda
- Q1 2023 Highlights
- Operational update
- Green visions for a blue future
- Financial update
- Outlook

Q1 2023 Highlights
- 125 MNOK in revenues, up 51% from Q1-22 driven by increased harvesting
- 28 MNOK in operating loss, compared to 45 MNOK in Q1-22
- 9 MNOK in cash flows from operations, up from -11 MNOK in Q1-22
- 3 362 tons WFE harvested, up from 2 027 tons WFE in Q1-22
- Second production site supplied with onshore power
Post Q1 2023 Highlights
- Measures to improve financial robustness and enable further growth
- 265 MNOK in gross proceeds from private placement and asset divestment
- Shareholder loan restructuring improving equity base
- Extension of overdraft facility from main bank
- GlobalG.A.P. recertified
- First cycle initiated at site Labukta

Operational update
- Process with the Directorate of Fisheries regarding suspicion of escape (not concluded on) and gonade development.
- Accelerated harvest and lower production volume.
- Shortened delivery on long-term sales contracts and lower sales prices due to increased sales on the spot market.
- We have initiated heavy measures to reduce risk and more robustly meet biological challenges.
- Norcod will continue to lead the development of Norwegian cod farming and recognizes the responsibility it entails.
- Good cooperation with available facilities made it possible for all harvest capacity to be used. The situation led to a challenging market situation, but the fish reached the end user.
- Second production site Jamnungen supplied by onshore power.
- Norcod fortifies its role as the leading industry player in farm raised, sustainable, quality cod by following up on our strategy and promise of continuous reduction in CO2 emissions.

Green visions for a blue future
Norcod in a sustainable global food system
- Zero use of antibiotics
- Certified feed ingredients
- Best possible score regarding seabed surveys
- Hybrid-electric vessels and feed barges
- Highly nutritious and flavorful product good for everyone and the planet – Cod above the rest
- 90 % utilization of the cod for human consumption

Looking ahead
- Aiming to increase the survival rate to 90 % within 2030
- Targeting for 98 % utilization of the cod for human consumption
- 30 % reduction in carbon footprint by 2030 (Scope 1, 2, 3)
- Zero escape incidents
- Available tools not only to prevent and detect, but fully control maturation
| Devoted to |
|---|
| --------------- |
| People | Cod | Nature | Innovation & Profit |
|---|---|---|---|
| Human rights | Fish Welfare | The ocean | Research and development |
| Safe work environment |
Production environment | Local and global environment |
|
| Local communities |
Product quality | Biodiversity | Year-round harvest |
| Gender equality |
Increase yield |
Responsible producer |
|
| Aquaculture education |
Food safety | Fish feed | Market development |
| Customers | Climate action |

Financial Update - Highlights






Balance sheet development - Assets Balance sheet development – Equity and liabilities


Financial update– Profit and loss
| (Amounts in NOK '000) | Note | Q1 - 2023#### | Q1 - 2022 | 2022 |
|---|---|---|---|---|
| Operating revenue | 125 107 | 83 050 | 170 541 | |
| Cost of materials | 1 | 164 487 | 98 797 | 168 730 |
| Salaries and personnel expenses | 13 499 | 8 189 | 43 031 | |
| Depreciation and amortization | 4 998 | 2 731 | 16 032 | |
| Other operating expenses | 30 154 | 17 401 | 65 833 | |
| Operating expenses | 213 138 | 127 117 | 293 626 | |
| Operating profit/ loss(-) before fair value adj. of biomass | -88 031 | -44 067 | -123 085 | |
| Fair value adjustment biomass | 60 227 | -943 | -157 808 | |
| Operating profit/loss | -27 804 | -45 009 | -280 892 | |
| Share of profit/ loss(-) from associates Net financial items |
2 | -2 201 -12 762 |
-462 -954 |
1 798 -18 123 |
| Profit/loss before tax | -42 767 | -46 425 | -297 217 | |
| Income tax expenses | 0 | 0 | 0 | |
| Net profit/loss for the period | -42 767 | -46 425 | -297 217 | |
| Other comprehensive income | 0 | 0 | 0 | |
| Total comprehensive income for the period | -42 767 | -46 425 | -297 217 |

Financial update– Balance Sheet
| (Amounts in NOK '000) | Note | Q1 - 2023 | Q1 - 2022 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets | ||||
| Concessions, patents, licenses, trademarks and similar rights | 3 | 2 000 | 8 298 | 2 000 |
| Property, plant & equipment | 81 972 | 53 492 | 76 678 | |
| Right-of-use assets | 126 155 | 109 954 | 123 846 | |
| Investment in associated companies | 4 | 31 310 | 34 120 | 33 511 |
| Other investments | 4 | 502 | 1 003 | 502 |
| Other non-current receivables | 40 000 | 29 998 | 40 000 | |
| Deferred tax assets | 0 | 0 | 0 | |
| Total non-current assets | 281 938 | 236 865 | 276 536 | |
| Current assets | ||||
| Inventories | 10 089 | 5 296 | 8 712 | |
| Biological assets | 173 029 | 209 732 | 206 758 | |
| Short-term receivables | 58 321 | 36 259 | 46 427 | |
| Cash and cash equivalents | 4 284 | 11 295 | 3 412 | |
| Total current assets | 245 723 | 262 582 | 265 310 | |
| TOTAL ASSETS | 527 661 | 499 446 | 541 846 |

Financial update– Balance Sheet
| (Amounts in NOK '000) | Note | Q1 - 2023 | Q1 - 2022 | 2022 |
|---|---|---|---|---|
| EQUITY AND LIABILITIES | ||||
| Equity | ||||
| Share capital | 9 609 | 8 516 | 9 609 | |
| Treasury Shares | -3 706 | -3 706 | -3 706 | |
| Share premium | 553 043 | 386 563 | 553 043 | |
| Retained earnings | -425 034 | -128 583 | -382 267 | |
| Total equity | 133 912 | 262 789 | 176 679 | |
| Liabilities | ||||
| Non-current interest-bearing debt | 5 | 0 | 74 736 | 0 |
| Lease liabilities | 61 044 | 57 549 | 60 939 | |
| Total non-current liabilities | 61 044 | 132 285 | 60 939 | |
| Current leasing Liabilities | 17 453 | 12 946 | 16 275 | |
| Current interest-bearing debt | 5 | 172 511 | -0 | 158 151 |
| Trade payables | 119 125 | 68 777 | 114 263 | |
| Other current liabilities | 23 616 | 22 649 | 15 540 | |
| Total current liabilities | 332 706 | 104 372 | 304 228 | |
| TOTAL EQUITY AND LIABILITIES | 527 662 | 499 446 | 541 846 |

Financial update– Cash flows
| Note (Amounts in NOK '000) Audited Profit/loss before tax -42 767 -45 021 -297 217 Cash flow from operating activities Depreciation and amortization 4 998 2 731 16 032 Impairment of intangible assets 0 Change in inventory and biological assets 1 32 352 24 753 -132 554 Fair value adjustment 0 157 808 Share of profit/ loss(-) from associates 2 201 0 -1 798 Change in accounts receivable -14 431 609 929 Change in accounts payable 4 862 -19 449 26 037 Change in other current receivables and other current liabilities 21 385 25 042 28 987 Net cash flow from operating activities 8 601 -11 335 -201 777 Cash flows from investing activities Payments for purchase of property, plant & equipment -7 382 -2 836 -36978 Payments for licences 0 -259 0 Capital contribution to associated companies 0 0 Proceeds from sale-leaseback transaction 0 0 Other investments 0 0 Loan to associated company 0 -10 000 Net cash flow from investing activities -7 382 -3 095 -46 978 Cash flows from financing activities Receipts from new debt 4 297 70 144 Repayment of lease liability -3 936 -3 005 -12 523 Interest paid 2 -708 -688 -2 421 Proceeds from issues of shares 0 167 549 |
Q1 - 2023 | Q1 - 2022 | 2022 | |
|---|---|---|---|---|
| Net cash flow from financing activities -346 -3 693 222 749 |
||||
| Net (decrease)/increase in cash and cash equivalents 872 -18 123 -26 006 |
||||
| Cash and cash equivalents at the beginning of the period 3 412 29 418 29 418 |
||||
| Cash and cash equivalents at close of the period 4 284 11 295 3 412 |

Outlook
- There has been extensive learning through the process which the company has been exposed to throughout Q1.
- Norcod is determined to further develop operational control parameters and build on an already welldeveloped quality and control system which e.g., embraces production, equipment, HSE and fish welfare.
- Both internally and in collaboration with industry colleagues and other stakeholders, we work on strategy and plans to prevent and eliminate risk.
- In order to postpone and reduce gonad development in our cod, new light regimes are set up on a large scale.
- Furthermore, measures such as sorting during the cycle will be carried out.
- Further development of ultrasound monitoring with regard to gonad development and for possible gender sorting will be a measure which it is realistic to assume can contribute to a long-term solution.
- The possibility of producing sterile cod is also being looked at and is a measure that is placed somewhat in the future.
- The main goal is to establish best practices in cod farming to safeguard a predictable and holistic context for everyone involved.
- Subsequent to the quarter Norcod recieved the good news of achieved GlobalG.A.P. recertification. It is of great importance to be able to refer to a third-party assessment.
- Our fifth production site, Labukta, kicked off its stocking of the 2023-generation in April. This wellequipped location is configrated with the most energy efficient technology seen in Norwegian aquaculture industry and is Norcod's second site supplied with onshore power.

Contact Info:
Arne Kristian Hoset CFO
Phone: +47 988 10 282 Email: [email protected]
More from Norcod
Director's Dealing
2026
May 13
Director's Dealing
2026
May 13
Director's Dealing
2026
May 13
Director's Dealing
2026
May 13
Director's Dealing
2026
May 13
Director's Dealing
2026
May 13
Director's Dealing
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Share Issue/Capital Change
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13